BRENUS-PHARMA
Brenus Pharma unveils groundbreaking results during the American Association Cancer Research (AACR) Annual meeting 2024 – San Diego (April 5-10).
“Efficacy of the STC-10101 a new allogeneic cancer vaccine in different colorectal cancer models” | Abstract 5003 https://doi.org/10.1158/1538-7445.AM2024-5003
This communication confirms the ability of Brenus’ next gen immunotherapy, STC-1010, to fight against resistant colorectal tumors with excellent tolerability.
Additionally, multi-omics analysis of STC-1010 batches confirmed consistent quality and batch-to-batch reproducibility, through standardized and scalable production.
STC-1010 was tested in several models extrapolating human conditions (ex-vivo; in-ovo,) using PBMCs from different donors. Results showed a significant immune response activation coupled with a massive and robust tumor killing that has been consistent with our 3 latest STC1010 batches manufactured. Metastasis reduction has also been shown with in-ovo model.
Results show the potential of STC-1010 in clinical settings to treat patients with colorectal cancer causing 9.7 million death per year.
- George ALZEEB2, galzeeb@brenus-pharma.com, Innovation Manager Manager (Ph.D)
- Céline GONGORA3, celine.gongora@inserm.fr, Research Director, Head of Team Inserm U1194 “Drug resistances and new cancer treatment” (Ph.D)
- Corentin RICHARD4, CRichard@cgfl.fr, Postdoctoral Bioiformatician (Ph.D)
- Romain BOIDOT3, rboidot@cgfl.fr, Molecular Biologist (Ph.D)
- Tanguy FORTIN5, tanguy.fortin@anaquant.com, Chief Executive Officer (Ph.D)
- Yan WANG6, yan.wang@inovotion.com, Scientist/R&D Project Manager (Ph.D)
- Alban BESSEDE7, a.bessede@explicyte.com, Chief Executive Officer (Ph.D)
- Benoit PINTEUR1, bpinteur@brenus-pharma.com, Chief Scientific Officer (Pharm D)
- Lionel CHALUS1, lchalus@brenus-pharma.com, Head of Technical Operation
- Corinne TORTORELLI1, ctortorelli@brenus-pharma.com, Senior Medical Lead (Pharm.D., Ph.D)
- Paul BRAVETTI1, pbravetti@brenus-pharma.com, Chief Executive Officer (Pharm D, MSc)
- François GHIRINGHELLI8, FGhiringhelli@cgfl.fr, Head of Team Inserm 1231 TIRECs «Therapies and Immune REsponse in CancerS », Director of early clinical unit CLIPP2, Professor of Oncology (M.D, PhD)
https://www.brenus-pharma.com/ | Follow us on LinkedIn
1 STC-1010 is a next-generation cancer immunotherapy produced by Allogeneic STC's proprietary Brenus platform. It’s specifically designed to combat colorectal cancer including MSS and MSI-H populations in its first line of treatment for the first indication. STC Platform mimics relapse conditions and allows eduction of patient’s immune system against resistant tumor.
2 Brenus Pharma, Lyon, France,
3 INSERM U1194 IRCM, Montpellier, France,
4 CNRS 6302, Dijon, France,
5 Anaquant, Lyon, France
6 Inovotion, La Tronche, France,
7 Explicyte, Bordeaux, France
8 Inserm 1231 CGFL, Dijon, France
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409632375/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Green Street Acquires Australian Property Journal to Expand Global Reach of Green Street News12.3.2025 20:00:00 CET | Press release
-- Global News Offering Now Covers More Than 20 Countries on 3 Continents -- Green Street, the leading provider of trusted commercial real estate intelligence and unbiased insights, has acquired Australian Property Journal – Australia’s premier publication for commercial property and residential real estate covering REITs, investment sales, and leasing transactions – to expand its global Green Street News offering. The growth of Green Street News into Australia will enable Green Street to continue its mission to empower the global commercial real estate community. “This expansion marks the latest major milestone in Green Street News' growth and Green Street's overall mission to empower the global Commercial Real Estate community. We are breaking ground not only in a new country, but on a new continent to provide the most actionable insights to ourconsumer base of high-level CRE professionals. We've assembled an incredible team of journalists with a fast-paced breaking news workflow to
Xsolla Releases Q1 2025 Report on the Future of Global Gaming and Game Development: Analysis of Metrics and Emerging Trends12.3.2025 18:00:00 CET | Press release
Key Topics Include the Global Gaming Market, Mobile Monetization Trends, Player Engagement Led by Gen Z and Gen Alpha, and Rising Investments Tools and Platforms Xsolla, a leading global video game commerce company, proudly announces the release of the Q1 2025 Edition of “The Xsolla Report: The State of Play.” This detailed report provides crucial insights, trends, and opportunities shaping the gaming landscape, empowering industry professionals to adapt and thrive in today’s rapidly changing market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311510072/en/ Graphic: Xsolla The Q1 2025 Edition focuses on the rapid growth of the global gaming market, which is expected to reach $522.5 billion in 2025 and expand at a 7.25% Compound Annual Growth Rate (CAGR), hitting $691.3 billion by 2029. The United States, poised to generate the largest revenue share for mobile games, will further solidify its position as the world’s top
Leasys finishes 2024 strong, posting full year results marked by consolidation and growth12.3.2025 17:02:00 CET | Press release
New contract activations: 243,000, +87% YoY Corporate customer fleet: 131,000 vehicles, +32% YoY Managed fleet: 906,000 vehicles, +4% Total Earning Assets: €10,2B, +36% YoY Gross Operating Margin (Net Banking Income): €388M, +12% YoY Cost-Income Ratio (excl. Margin on Used Car Sales): 51% Profit Before Taxes: €173M, +1% in line with 2023 Adjusted Net Income: €112M, in line with 2023 Leasys, the Stellantis-Crédit Agricole JV, achieved 243,000 contract activations in 2024, an 87% YoY growth. Highlights include a threefold increase in LCV contracts and a 50% rise in electrified vehicle contracts, reflecting strong resilience and strategic growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312504159/en/ Leasys Finishes 2024 Strong, Posting Full Year Results Marked by Consolidation and Growth (Graphic: Business Wire) Compared to 2023, Leasys increased its penetration on Stellantis sales by 9bps in the B2B channel and 21bps
Exein partners with Supermicro to redefine the future of embedded security12.3.2025 16:31:00 CET | Press release
Exein, the embedded IoT cybersecurity company, and Supermicro,a global leader in application-optimized total IT solutions, have announced a partnership to redefine embedded security. Exein and Supermicro’s collaboration will see Exein’s cutting-edge embedded security solutions integrated into Supermicro’s industry-leading hardware, ensuring unprecedented protection for enterprises worldwide. Together, Exein and Supermicro are raising the bar for cybersecurity in edge computing, IoT, and critical infrastructure—securing the future, one device at a time. With Exein’s AI-driven security built directly into Supermicro’s hardware, businesses can now deploy infrastructure with zero-trust security from the ground up—ensuring resilience against evolving cyber threats. "We are honored to partner with Supermicro to bring Exein’s next-generation embedded security to their industry-leading solutions. This collaboration ensures that security is not just an add-on, but an integral part of the hardwa
Andersen Global tilføjer Finaltus som strategisk værdiansættelsesekspert i Kenya12.3.2025 14:32:00 CET | Pressemeddelelse
Andersen Global styrker sin tilstedeværelse i Østafrika. Det sker via en samarbejdsaftale med Finaltus, et værdiansættelsesfirma med hovedkontor i Nairobi. Dermed forbedrer vi vores organisations formåen til at levere omfattende værdiansættelsesløsninger i hele regionen. Firmaet Finaltus opererer ud fra Nairobi og har specialiseret sig i transaktions- og investeringsrådgivning. Det dækker hele Østafrika. Firmaets erfaringsgrundlag spænder over mere end et årti inden for flere brancher. Der ydes ekspertbistand inden for transaktionsrådgivning om fusioner og opkøb, strukturering af offentlig-private partnerskaber, værdiansættelse og rådgivning af virksomheder, værdiansættelse i forbindelse med retssager, værdiansættelse af intellektuel ejendom, kapitalrejsning og rådgivning om udviklingsfinansiering. Firmaet har et team af erfarne eksperter, der kombinerer lokal ekspertise med global formåen til at levere effektive og stabile specialløsninger til kunder i brancher og på forskellige geogr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom